Drugs News and Research

RSS

Australian Government's decision to purchase sufficient influenza vaccine for the next three seasons is good health planning

Australian Medical Association Vice President, Dr Mukesh Haikerwal, has said the Australian Government's decision to purchase sufficient influenza vaccine for the next three seasons is good health planning.

6 Dec 2004

Researchers step closer to cure for common childhood cancer

Acute lymphoblastic leukemia (ALL) is a malignant disease caused by the abnormal growth and development of white blood cells (WBC) in the bone marrow and blood. ALL is the most common cancer occurring in children with an annual rate of approximately 30 to 40 new cases per million.

5 Dec 2004

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

5 Dec 2004

Genasense shown to enhance the anti-lymphoma activity of Velcade and Rituxan

Genta Incorporated announced that two new studies have shown that Genasense (oblimersen sodium) Injection, the Company's lead anticancer drug, showed synergistic activity with both bortezomib (Velcade; Millennium Pharmaceuticals, Inc.) and rituximab (Rituxan; Genentech, Idec) in experimental models of B-cell non-Hodgkin's lymphoma (NHL).

5 Dec 2004

A gallery of highly-specific, gene and protein “mug shots” of cancer types would be a powerful for oncologists

Doctors would like to diagnose malignancies rapidly by matching them with highly-specific genetic “mug shots” based on the presence of characteristic mRNAs or proteins. This kind of specificity would facilitate screening and early detection, and would potentially allow targeted treatments specific to each type of cancer

4 Dec 2004

Oral targeted therapy shows benefit in treating high-risk myelodysplastic syndrome

An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating high-risk myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML)

4 Dec 2004

Phase 3 results of Genasense plus Dexamethasone in patients with advanced multiple myeloma

Genta Incorporated announced that results from the Company's randomized Phase 3 clinical trial of Genasense(R) (oblimersen sodium) Injection in patients with relapsed or refractory multiple myeloma were presented today at the annual meeting of the American Society of Hematology (ASH) in San Diego, CA.

4 Dec 2004

Study focused on patients with chemotherapy-related anemia

Findings from an interim analysis of a new study comparing the hemoglobin response rates of Epoetin alfa and darbepoetin alfa in the treatment of chemotherapy-related anemia were published in the November 15, 2004 issue of the Medical Journal 'Blood' as part of the American Society of Hematology 46th Annual Meeting and Exposition.

4 Dec 2004

Life expectancy at 65 is now 81.6 years for men and 84.5 for women

The nation’s medicine cabinets are more crowded than ever, with almost half of all people taking at least one prescription medicine and one in six taking three or more medications, according to the U.S. Department of Health and Human Services’ annual check-up on Americans’ health.

4 Dec 2004

New noninvasive technique allows for early detection of chemotherapy treatment response

Scientists at the Arizona Cancer Center have developed an approach that will allow them to detect if cancer patients are responding within days after they start a new chemotherapy regimen.

4 Dec 2004

More than 11 million children in developing countries die every year from preventable illness

More than 11 million children in developing countries die every year from preventable illness, while as many as 500 000 women don't survive during pregnancy or childbirth. More than 39 million people are living with HIV/AIDS and the epidemic is growing.

4 Dec 2004

Medicines used to treat parasitic infections have much wider benefits than was previously thought

Encouraging new data from the wider distribution of anti-parasite drugs in pregnant women and very young children demonstrates that medicines commonly used to treat parasitic infections have much wider benefits than was previously thought.

4 Dec 2004

People could be exposed to antibiotic-resistant bacteria from breathing air from swine feeding facilities

People could be exposed to antibiotic-resistant bacteria from breathing the air from concentrated swine feeding facilities, according to researchers at the Johns Hopkins Bloomberg School of Public Health.

4 Dec 2004

300 million people in the developing world are seriously ill from intestinal worms

300 million people in the developing world are seriously ill from intestinal worms. Treatment is cheap and effective—and if successfully delivered with other public-health measures could make a substantial contribution to achieving many of the world’s Millennium development Goals (MDGs), concludes the lead editorial in this week’s issue of THE LANCET.

4 Dec 2004

Drugs News and Research

Australian Government's decision to purchase sufficient influenza vaccine for the next three seasons is good health planning

Researchers step closer to cure for common childhood cancer

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

Genasense shown to enhance the anti-lymphoma activity of Velcade and Rituxan

A gallery of highly-specific, gene and protein “mug shots” of cancer types would be a powerful for oncologists

Oral targeted therapy shows benefit in treating high-risk myelodysplastic syndrome

Phase 3 results of Genasense plus Dexamethasone in patients with advanced multiple myeloma

Study focused on patients with chemotherapy-related anemia

Life expectancy at 65 is now 81.6 years for men and 84.5 for women

New noninvasive technique allows for early detection of chemotherapy treatment response

More than 11 million children in developing countries die every year from preventable illness

Medicines used to treat parasitic infections have much wider benefits than was previously thought

People could be exposed to antibiotic-resistant bacteria from breathing air from swine feeding facilities

300 million people in the developing world are seriously ill from intestinal worms

Medication errors in sick children might be substantially higher than previously estimated

Important step in understanding why some of us can eat fatty foods and not suffer from cardiac disease

New devices for people who suffer dry mouth or lack of saliva

Smoking habits during pregnancy may cause genetic instability in the foetus

Frequent cannabis use increases the risk of psychotic symptoms

Higher incidence of rejection following early steroid withdrawal

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News